Skip to content

Depression research published in 2021

247 studies whose primary subject is depression were published in 2021, up from 169 in 2020. Newest first. Back to the depression overview

Studies

Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review

BJPsych Open December 23, 2021 Zach Walsh, Özden Merve Mollaahmetoğlu, Joseph M. Rootman et al. 180 citations

Background In the past two decades, subanaesthetic doses of ketamine have been demonstrated to have rapid and sustained antidepressant effects, and accumulating research has demonstrated ketamine's therapeutic effects for a range of psychiatric conditions. Aims In light of these findings surrounding ketamine's psychotherapeutic potential, we systematically review the extant evidence on...

REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial.

American Journal of Psychiatry December 22, 2021 Maurizio Fava, S. Stahl, Luca Pani et al.

OBJECTIVE The purpose of this study was to examine the effects of REL-1017 (esmethadone), a novel N-methyl-d-aspartate receptor (NMDAR) channel blocker, in patients with major depressive disorder who failed to benefit from one to three standard antidepressant treatments in their current major depressive episode. METHODS A 7-day phase 2 multicenter randomized double-blind placebo-controlled...

Mindfulness based cognitive therapy (MBCT) reduces depression-related self-referential processing in patients with bipolar disorder: an exploratory task-based study

Cognition & Emotion December 22, 2021 Thalia D.M. Stalmeier, Jelle Lubbers, Mira B. Cladder-Micus et al.

ABSTRACT Negative self-referential processing has fruitfully been studied in unipolar depressed patients, but remarkably less in patients with bipolar disorder (BD). This exploratory study examines the relation between task-based self-referential processing and depressive symptoms in BD and their possible importance to the working mechanism of mindfulness-based cognitive therapy (MBCT) for BD....

Overcoming Depression with 5-HT2A Receptor Ligands

International Journal of Molecular Sciences December 21, 2021 Agata Zięba, Piotr Stępnicki, Dariusz Matosiuk et al. 55 citations

Depression is a multifactorial disorder that affects millions of people worldwide, and none of the currently available therapeutics can completely cure it. Thus, there is a need for developing novel, potent, and safer agents. Recent medicinal chemistry findings on the structure and function of the serotonin 2A (5-HT2A) receptor facilitated design and discovery of novel compounds with...

DOI: 10.3390/ijms23010010 (opens in new tab) Virtual screening Receptor Depression economics Antidepressant +3

Electroconvulsive therapy in treatment resistant depression: What is new?

Psychiatriki December 20, 2021 Styliani Kaliora 1 citation

Despite major advances in the treatment of mood disorders, major depression, a common mental disorder, remains a serious public health problem. Electroconvulsive therapy (ECT) regardless of the anesthetic agent used, is the most effective form of treatment in major depression and the gold standard therapy in treatment resistant depression. Ketamine is one of the anesthetic drugs approved by the...

Ketamine infusion therapy in treatment-resistant depression

Psychiatriki December 20, 2021 Τheodosios Ε Christodoulakis 1 citation

Τhe Food and Drug Administration (FDA) approval of the use of S-ketamine in the form of nasal spray for the treatment of treatment-resistant depression, launched a new category of therapeutic agents in psychiatry. A well-known class of substances, psychedelics, are introduced with a 30-year delay in the treatment of mental disorders. Intravenous ketamine infusion has been studied in the...

The role of ketamine in the treatment of treatment-resistant bipolar depression

Psychiatriki December 20, 2021 Grigorios N. Karakatsoulis, Eva-Maria Tsapakis, Konstantinos Ν. Fountoulakis 1 citation

Treatment-Resistant Depression (TRD) calls for the development of effective interventions for mood elevation and stabilization. Recently, both ketamine and its S-enantiomer (esketamine) have been investigated with successful clinical trials demonstrating effectiveness in TRD. More specifically, in 2019, intranasally administered esketamine, as opposed to the more effective intravenous ketamine,...

Effectiveness of online mindfulness interventions on medical students' mental health: a systematic review.

BMC Public Health December 18, 2021 Vaidehi Yogeswaran, Christo El Morr

Background: Medical school typically presents students with a combination of academic and personal stressors that may lead to substandard mental health wellbeing. Meditation practices such as mindfulness facilitate a greater awareness of one's thoughts and feelings, thereby decreasing emotional reactivity. The use of mindfulness-based interventions delivered online has considerable potential in...

Mindfulness-Based Program for Anxiety and Depression Treatment in Healthcare Professionals: A Pilot Randomized Controlled Trial.

Journal of Clinical Medicine December 17, 2021 Mirian Santamaría-Peláez, Jerónimo Javier González-Bernal, Juan Carlos Verdes-Montenegro-Atalaya et al.

In primary health care, the work environment can cause high levels of anxiety and depression, triggering relevant expert and individual change. Mindfulness-Based Stress Reduction (MBSR) programs reduce signs of anxiety and depression. The purpose of this sub-analysis of the total project, was to equate the effectiveness of the standard MBSR curriculum with the abbreviated version in minimizing...

S-ketamine as an adjuvant in patient-controlled intravenous analgesia for preventing postpartum depression: a randomized controlled trial

BMC Anesthesiology December 16, 2021 Yaqian Han, Pule Li, Mengrong Miao et al.

Background Postpartum depression (PPD) is a common complication of cesarean section. S-ketamine given intravenously during surgery can help prevent PPD. However, whether S-ketamine in patient-controlled intravenous analgesia (PCIA) can reduce the incidence of PPD is unknown. This study assessed the effect of S-ketamine as an adjuvant in PCIA for preventing PPD in women undergoing cesarean...

Mindfulness predicts less depression, anxiety, and social impairment in emergency care personnel: A longitudinal study

PLoS One December 15, 2021 Maren Westphal, Melanie M. Wall, Thomas Corbeil et al. 21 citations

Medical personnel working in emergency rooms (ER) are at increased risk of mental health problems and suicidality. There is increasing evidence that mindfulness-based interventions can improve burnout and other mental health outcomes in health care providers. In contrast, few longitudinal prospective studies have examined protective functions of dispositional mindfulness in this population. The...

A Qualitative Study Comparing the Experiences of the Meditation-Based Lifestyle Modification Program with Multi-professional Psychiatric Treatment for Female Outpatients with Mild to Moderate Depression

OBM Integrative and Complementary Medicine December 14, 2021 Julian Gross, Karin Matko, Jill Vennemann et al. 3 citations

Meditation-Based Lifestyle Modification (MBLM) is a complex eight-week mind-body intervention based on the traditional eight-fold path of classical yoga. MBLM was developed for mental health care, and it combines ethical living, physical yoga, and meditation. In this qualitative study, the subjectively perceived efficacy of MBLM was compared to the perceived efficacy of an individually...

Mechanisms of the Rapid Effects of Ketamine on Depression and Sleep Disturbances: A Narrative Review

Frontiers in Pharmacology December 14, 2021 Bijia Song, Junchao Zhu

Recently, sleep has been recognized as a crucial factor for health and longevity. The daily sleep/wake cycle provides the basis of biorhythm, which controls whole-body homeostasis and homeodynamics. Sleep disturbances can contribute to several physical and psychological disorders, including cardiovascular disease, obesity, depression, and cognitive dysfunction. The clinical use of the...

Reductions in experiential avoidance explain changes in anxiety, depression and well-being after a mindfulness and self-compassion (MSC) training.

Psychology and Psychotherapy Theory Research and Practice December 13, 2021 J. R. Yela, Antonio L Crego, Jose Buz et al.

OBJECTIVE The mindfulness and self-compassion (MSC) protocol has shown efficacy in reducing mental illness symptoms and increasing well-being. However, little is known on how the positive outcomes are produced. This study explores how reductions in experiential avoidance following MSC training may explain changes in the participants' levels of anxiety, depression, and well-being. METHODS The...

Effects of Mindfulness-Based Stress Reduction (MBSR) Program on Anxiety and Depression and HRQoL among Cancer Patients in Malaysia.

Environment-Behaviour Proceedings Journal December 12, 2021 Che Noriah Binti Othman, Syed Azhar Syed Sulaiman, Maryam Farooqui et al.

Anxiety and depression are common among cancer patients and impact health-related quality of life. MBSR has long been used to treat psychological illnesses in various therapeutic settings worldwide. However, there is no solid evidence of MBSR effects among cancer patients in Malaysia. This cross-sectional study intervened in the five weeks of MBSR on cancer patients in Penang. Results found...

Racemic Ketamine as an Alternative to Electroconvulsive Therapy for Unipolar Depression: A Randomized, Open-Label, Non-Inferiority Trial (KetECT)

The International Journal of Neuropsychopharmacology December 4, 2021 Joakim Ekstrand, Christian Fattah, Marcus Persson et al. 112 citations

Abstract Background Ketamine has emerged as a fast-acting and powerful antidepressant, but no head to head trial has been performed, Here, ketamine is compared with electroconvulsive therapy (ECT), the most effective therapy for depression. Methods Hospitalized patients with unipolar depression were randomized (1:1) to thrice-weekly racemic ketamine (0.5 mg/kg) infusions or ECT in a parallel,...

Case Report: Repeated Series of Ketamine Infusions in Patients With Treatment-Resistant Depression: Presentation of Five Cases

Frontiers in Psychiatry December 2, 2021 Maria Gałuszko‐węgielnik, Adam Włodarczyk, Wiesław Jerzy Cubała et al. 5 citations

Purpose: Approximately 30% of patients with major depressive disorder (MDD) are treatment resistant. There is an unquestionable need for new treatment strategies. Subanesthetic doses of intravenous (IV) ketamine have a rapid antidepressant effect in treatment-resistant depression (TRD). This paper describes the efficacy of repeated series of intravenous ketamine infusions as an add-on treatment...

Ketamine vs Midazolam: Mood Improvement Reduces Suicidal Ideation in Depression

Journal of Affective Disorders December 1, 2021 Annabella Hochschild, John G Keilp, Sean P Madden et al.

Objective: Studies demonstrate rapid antidepressant and anti-suicidal ideation effects of subanesthetic ketamine. The specific subcomponents of depression that are most closely tied to reduction of suicidal ideation with ketamine treatment are less explored. Methods: Exploratory, post hoc analysis of data from a randomized clinical trial of ketamine vs midazolam in patients with major...

Comparative effectiveness of repeated ketamine infusions in treating anhedonia in bipolar and unipolar depression.

Journal of Affective Disorders December 1, 2021 Wei Zheng, Lingna Gu, Chen-Hui Sun et al.

OBJECTIVES Anhedonia is a common, persistent, and disabling phenomenon in patients with major depressive disorder (MDD) and bipolar depression (BD). This study was conducted to investigate the comparative effectiveness of repeated ketamine infusions in treating anhedonia in Chinese individuals suffering from MDD and BD. METHODS Ninety-seven individuals suffering from MDD (n=77) or BD (n=20)...

P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression – a comprehensive literature review

European Neuropsychopharmacology December 1, 2021 S. Penedos, C. Ramos, M. Miguel et al. 1 citation

Introduction: Psychedelics have seen various labels: mystical sacrament aids, potential interrogation tools for the Cold War, agents for social change in the Hippie counter movement, a panacea for various mental disorders, and a tool to “hack” of the psyche. This has led to their reputation as both societal threat and a psychopharmacological breakthrough. After the loss of data on over 1000...